Biofarma increases production of vaccines by 4.5 million vials

Biofarma increases production of vaccines by 4.5 million vials

PT Bio Farma (Persero) production vaccine containing diphtheria component before being distributed, in Bandung, West Java, on Monday (Dec. 18, 2017). (ANTARA /M. Agung Rajasa)

We have to work extra time from five days to seven days a week to meet the vaccine requirement."
Jakarta (ANTARA News) - Vaccine producer PT Bio Farma said it has increased its vaccine production by 4.5 million vials to meet a surge in demand for "Outbreak Response Immunization" (ORI) with the outbreak of diphtheria in various areas in the country.

Chief Executive of PT Bio Farma Juliman said at a discussion on on diphtheria here on Friday said the company`s production of vaccines rose to 19.5 million vials from normally 15 million.

"We have to work extra time from five days to seven days a week to meet the vaccine requirement," Juliman said.

The production capacity of Bio Farma is 15 million vials a year with 5 working days a week. The production capacity could be expanded to 19.5 million vials with seven working days a week.

The production capacity of 15 million vials includes for tetanus and hepatitis B vaccines, but production of tetanus and hepatitis B vaccines is reduced to increase diphtheria vaccine production.

Juliman said his company has to put off exports to meet the increase in domestic requirement.

Health Minister Nila Moeloek said diphtheria vaccines and anti diphtheria serum (ADS) are sufficiently available for outbreak response immunization.
(Uu.H-ASG/B003)

Comments